Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Common and rare genetic variants of complement components in human disease

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. The ficolin response to LPS challenge in mice

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Amyotrophic lateral sclerosis: The complement and inflammatory hypothesis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Complement activation by cholesterol crystals triggers a subsequent cytokine response

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Ficolins and the lectin pathway of complement in patients with systemic lupus erythematosus

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Proteomics-Based Comparative Mapping of the Secretomes of Human Brown and White Adipocytes Reveals EPDR1 as a Novel Batokine

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Expression of complement C3, C5, C3aR and C5aR1 genes in resting and activated CD4+ T cells

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Collecting the collectins of complement

    Publikation: Bog/antologi/afhandling/rapportPh.d.-afhandlingForskning

  • Elena Goicoechea de Jorge
  • Alberto López Lera
  • Rafael Bayarri-Olmos
  • Hugo Yebenes
  • Margarita Lopez-Trascasa
  • Santiago Rodríguez de Córdoba
Vis graf over relationer

Genetic variability in the complement system and its association with disease has been known for more than 50 years, but only during the last decade have we begun to understand how this complement genetic variability contributes to the development of diseases. A number of reports have described important genotype-phenotype correlations that associate particular diseases with genetic variants altering specific aspects of the activation and regulation of the complement system. The detailed functional characterization of some of these genetic variants provided key insights into the pathogenic mechanisms underlying these pathologies, which is facilitating the design of specific anti-complement therapies. Importantly, these analyses have sometimes revealed unknown features of the complement proteins. As a whole, these advances have delineated the functional implications of genetic variability in the complement system, which supports the implementation of a precision medicine approach based on the complement genetic makeup of the patients. Here we provide an overview of rare complement variants and common polymorphisms associated with disease and discuss what we have learned from them.

OriginalsprogEngelsk
TidsskriftMolecular Immunology
Vol/bind102
Sider (fra-til)42-57
Antal sider16
ISSN0161-5890
DOI
StatusUdgivet - okt. 2018

ID: 56258863